These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37324953)

  • 1. SLC5A3 is important for cervical cancer cell growth.
    Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L
    Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy.
    Andronic J; Shirakashi R; Pickel SU; Westerling KM; Klein T; Holm T; Sauer M; Sukhorukov VL
    PLoS One; 2015; 10(3):e0119990. PubMed ID: 25756525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
    Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
    Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell-specific molecule 1 drives cervical cancer progression.
    Lu J; Liu Q; Zhu L; Liu Y; Zhu X; Peng S; Chen M; Li P
    Cell Death Dis; 2022 Dec; 13(12):1043. PubMed ID: 36522312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium.
    Chauvin TR; Griswold MD
    Biol Reprod; 2004 Mar; 70(3):744-51. PubMed ID: 14613899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis.
    De Paepe B; Merckx C; Jarošová J; Cannizzaro M; De Bleecker JL
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia.
    Wei Y; Huang YH; Skopelitis DS; Iyer SV; Costa ASH; Yang Z; Kramer M; Adelman ER; Klingbeil O; Demerdash OE; Polyanskaya SA; Chang K; Goodwin S; Hodges E; McCombie WR; Figueroa ME; Vakoc CR
    Cancer Discov; 2022 Feb; 12(2):450-467. PubMed ID: 34531253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMX/Etk promotes cell proliferation and tumorigenicity of cervical cancer cells through PI3K/AKT/mTOR and STAT3 pathways.
    Li Y; Cui N; Zheng PS; Yang WT
    Oncotarget; 2017 Jul; 8(30):49238-49252. PubMed ID: 28514765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.
    Hu W; Hu Y; Pei Y; Li R; Xu F; Chi X; Mi J; Bergquist J; Lu L; Zhang L; Yang C
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular regulation of cervical cancer growth and invasion by VEGFa.
    Chen B; Zhang C; Dong P; Guo Y; Mu N
    Tumour Biol; 2014 Nov; 35(11):11587-93. PubMed ID: 25135429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain.
    Buccafusca R; Venditti CP; Kenyon LC; Johanson RA; Van Bockstaele E; Ren J; Pagliardini S; Minarcik J; Golden JA; Coady MJ; Greer JJ; Berry GT
    Mol Genet Metab; 2008; 95(1-2):81-95. PubMed ID: 18675571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.